Coloplast ASCLPBF 72 Operating Margin % is 25.69% as of Mar. 2026, which is 17% below its 10-year median of 30.96. GuruFocus rates CLPBF with a GF Score™ of 72/100 and a GF Value™ of $126.91 (Significantly Undervalued). The stock has 7 warning signs investors should review. Among 816 Medical Devices & Instruments companies, Coloplast AS ranks better than 92.89% on this metric.
Operating Margin % is calculated as Operating Income divided by its Revenue. Coloplast AS's Operating Income for the
three
months ended in Mar. 2026 was $282 Mil. Coloplast AS's Revenue for the
three
months ended in Mar. 2026 was $1,096 Mil. Therefore, Coloplast AS's Operating Margin % for the quarter that ended in Mar. 2026 was 25.69%.
Warning Sign:
Coloplast AS operating margin has been in a 5-year decline. The average rate of decline per year is -3.8%.
The historical rank and industry rank for Coloplast AS's Operating Margin % or its related term are showing as below:
CLPBF'
s Operating Margin % Range Over the Past 10 Years
Min: 26.88 Med: 30.96 Max: 33.01
Current: 26.88
CLPBF's Operating Margin % is ranked better than 92.89% of 816
companies
in the Medical Devices & Instruments industry
Industry Median: 3.465
vs CLPBF: 26.88
Coloplast AS's 5-Year Average Operating Margin % Growth Rate was -3.80% per year.
Coloplast AS's Operating Income for the
three
months ended in Mar. 2026 was $282 Mil.
Its Operating Income for the trailing twelve months (TTM) ended in Mar. 2026 was $1,175 Mil.
Coloplast AS (OTCPK:CLPBF) Operating Margin % Explanation
Just like Gross Margin %, it is important to see a company maintains its operating margin over time. Among the same industry, a company with higher operating margin is more efficient in its operation. It is also more stable during industry slowdown or recessions. Peter Lynch prefers those with higher margins than those with lower margins.
Be Aware
Operating Margin % can be manipulated by adjusting the rate of depreciation, depletion and amortization (DDA).
If a company is facing competition, its Operating Margin % may decline. Often the Operating Margin % declines well before the company's Revenue or even profit decline. Therefore, Operating Margin % is a very important indicator of whether the company is facing problems.
For instance, by 2012, Nokia (NOK)'s problems were well known and its stock had lost more than 90% of its market value since 2007. But Nokias Operating Margin % had already been in decline since 2002, although its Earnings per Share (Diluted) were still rising. Investors who paid attention to Operating Margin % would have avoided this huge loss. The same can be said for Research-in-Motion (RIMM).
Therefore, Operating Margin % is a very important screening filter for GuruFocus. GuruFocus's Buffett-Munger screener requires that the profit margin is either consistent or expanding. The Model Portfolio of the Buffett-Munger screener has outperformed the market every year since inception in 2009.
Coloplast AS Operating Margin % Related Terms
Coloplast AS Operating Margin % Historical Data
* Premium members only.
The historical data trend for Coloplast AS's Operating Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
CLPBF vs ISRG, BDX, MDLN: Operating Margin % Comparison
For the Medical Instruments & Supplies subindustry, Coloplast AS's Operating Margin %, along with its competitors' market caps and Operating Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Coloplast AS Operating Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Coloplast AS's Operating Margin % distribution charts can be found below:
* The bar in red indicates where Coloplast AS's Operating Margin % falls into.
Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.
Coloplast AS's Operating Margin % for the fiscal year that ended in Sep. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Coloplast AS (CLPBF) has a Operating Margin % of 25.69% as of Mar. 2026. Operating margin is the ratio of total operating income to net sales. View historical data on Coloplast AS and its competitors. This is 17% below median its historical median of 30.96. Over the past decade, Coloplast AS's Operating Margin % has ranged from 26.88 to 33.01. According to the industry distribution chart, Coloplast AS ranks #58 out of 816 companies in the Medical Devices & Instruments industry, placing it in the top 7.1%.
Is Coloplast AS's Operating Margin % too high?
Coloplast AS's current Operating Margin % of 25.69% is 17% below median its 10-year median of 30.96. Over the past 10 years, this metric has ranged from a low of 26.88 to a high of 33.01. The Medical Devices & Instruments industry median Operating Margin % is 3.47. Coloplast AS's value of 25.69% is 641.4% above this industry median. Based on the distribution chart, Coloplast AS ranks #58 out of 816 companies in the Medical Devices & Instruments industry, which is in the top quartile — a strong position relative to peers. Overall, Coloplast AS has a GF Score™ of 72/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Coloplast AS's Operating Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Coloplast AS ranks #58 out of 816 companies for Operating Margin %. This places Coloplast AS in the top 7% of its industry — outperforming the majority of peers. The industry median Operating Margin % is 3.47. Coloplast AS's value of 25.69% is 641.4% above this benchmark. Historically, Coloplast AS's own Operating Margin % has ranged from 26.88 to 33.01 over the past decade. While the company's 10-year median is 30.96 vs. the industry median of 3.47, Coloplast AS has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Operating Margin % for a Medical Devices & Instruments company?
The median Operating Margin % among Medical Devices & Instruments companies is 3.47, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a Operating Margin % significantly above this median, while those in the bottom quartile fall well below. However, Operating Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Coloplast AS's current Operating Margin % of 25.69% is 641.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Operating Margin % mean?
A high Operating Margin % can signal that a stock is expensive relative to its fundamentals. Operating margin is the ratio of total operating income to net sales. View historical data on Coloplast AS and its competitors. For the Medical Devices & Instruments industry, the median Operating Margin % is 3.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Coloplast AS's current Operating Margin % is 25.69%, which is 17% below median its own 10-year median of 30.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Coloplast AS stock overvalued right now?
Based on GuruFocus' analysis, Coloplast AS (CLPBF) is currently considered Significantly Undervalued. The stock's GF Value™ is $126.91, compared to a current price of $57.41 — trading 54.8% below its estimated fair value. The current Operating Margin % is 25.69%, which is 17% below median its 10-year median of 30.96 and 641.4% above the Medical Devices & Instruments industry median of 3.47. Coloplast AS's overall GF Score™ is 72/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Operating Margin % calculated?
Operating Margin % is calculated from a company's financial statements. For Coloplast AS (CLPBF), the current Operating Margin % is 25.69% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Coloplast AS (CLPBF) Overvalued in 2026?
Based on GuruFocus' analysis, Coloplast AS stock appears to be undervalued.
The current stock price of $57.41 is trading 54.8% below its estimated GF Value™ of $126.91.
GuruFocus considers Coloplast AS to be Significantly Undervalued.
Key valuation signals for CLPBF:
Operating Margin %: 25.69% (17% below median its 10-year median of 30.96)
GF Value™: $126.91 vs. price of $57.41 (54.8% below fair value)
Industry Position: 641.4% above the Medical Devices & Instruments median (#58 of 816)
No single metric tells the full story. See the CLPBF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Coloplast is a leading global competitor in ostomy management and continence care. The firm designs, manufactures, and markets ostomy care systems, disposable containment devices, intermittent catheters for continence care, and devices for patients with neck stomas. Coloplast also maintains a tertiary presence in the urology and woundcare markets, where it manufactures and markets penile implants, slings for incontinence and prolapse, and wound dressings. The company derives more than 60% of sales from Europe, 24% from other developed countries, and 17% from the rest of the world.
72GF Score
Get the complete analysis for CLPBF
Operating Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLPBF has been successfully added to your 
